AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management
Authors: Greco, M Crippa, F Agresti, R Seregni, E Gerali, A Giovanazzi, R Micheli, A Asero, S Ferraris, C Gennaro, M Bombardieri, E Cascinelli, N
Citation: M. Greco et al., Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management, J NAT CANC, 93(8), 2001, pp. 630-635
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables
Authors: Menard, S Valagussa, P Pilotti, S Gianni, L Biganzoli, E Boracchi, P Tomasic, G Casalini, P Marubini, E Colnaghi, MI Cascinelli, N Bonadonna, G
Citation: S. Menard et al., Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables, J CL ONCOL, 19(2), 2001, pp. 329-335
Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system
Authors: Balch, CM Soong, SJ Gershenwald, JE Thompson, JF Reintgen, DS Cascinelli, N Urist, M McMasters, KM Ross, MI Kirkwood, JM Atkins, MB Thompson, JA Coit, DG Byrd, D Desmond, R Zhang, YT Liu, PY Lyman, GH Morabito, A
Citation: Cm. Balch et al., Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system, J CL ONCOL, 19(16), 2001, pp. 3622-3634
Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma
Authors: Balch, CM Buzaid, AC Soong, SJ Atkins, MB Cascinelli, N Coit, DG Fleming, ID Gershenwald, JE Houghton, A Kirkwood, JM McMasters, KM Mihm, MF Morton, DL Reintgen, DS Ross, MI Sober, A Thompson, JA Thompson, JF
Citation: Cm. Balch et al., Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma, J CL ONCOL, 19(16), 2001, pp. 3635-3648
The new melanoma staging system
Authors: Balch, CM Cascinelli, N
Citation: Cm. Balch et N. Cascinelli, The new melanoma staging system, TUMORI, 87(4), 2001, pp. S64-S68
A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma
Authors: Bajetta, E Del Vecchio, M Vitali, M Martinetti, A Ferrari, L Queirolo, P Sertoli, MR Cainelli, T Cellerino, R Cascinelli, N
Citation: E. Bajetta et al., A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma, TUMORI, 87(4), 2001, pp. 219-222
Surgical treatment of gastric metastases from cutaneous melanoma: Experience of the National Cancer Institute of Milan
Authors: Gallino, G Belli, F Bonfanti, G Ditto, A Andreola, S Tragni, G Massone, PPB Civelli, E Vitellaro, M Leo, E Cascinelli, N
Citation: G. Gallino et al., Surgical treatment of gastric metastases from cutaneous melanoma: Experience of the National Cancer Institute of Milan, TUMORI, 87(4), 2001, pp. 229-231
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial
Authors: Cascinelli, N Belli, F MacKie, RM Santinami, M Bufalino, R Morabito, A
Citation: N. Cascinelli et al., Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial, LANCET, 358(9285), 2001, pp. 866-869
Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Programexperience
Authors: Cascinelli, N Belli, F Santinami, M Fait, V Testori, A Ruka, W Cavaliere, R Mozzillo, N Rossi, CR MacKie, RM Nieweg, O Pace, M Kirov, K
Citation: N. Cascinelli et al., Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Programexperience, ANN SURG O, 7(6), 2000, pp. 469-474
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999)
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Santantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999), HUM GENE TH, 11(6), 2000, pp. 981-981
What is the most promising strategy for the treatment of metastasizing melanoma?
Authors: Cascinelli, N Heerlyn, M Schneeberger, A Kuwert, C Slominski, A Armstrong, C Belli, F Lukiewcz, S Maurer, D Ansel, J Stingl, G Saida, T
Citation: N. Cascinelli et al., What is the most promising strategy for the treatment of metastasizing melanoma?, EXP DERMATO, 9(6), 2000, pp. 439-451
Unusual association between cutaneous melanoma and axillary metastasis from occult breast cancer detected by sentinel node biopsy
Authors: Gallino, G Belli, F Greco, M Maffioli, L Ferro, F Massone, PPB Cascinelli, N
Citation: G. Gallino et al., Unusual association between cutaneous melanoma and axillary metastasis from occult breast cancer detected by sentinel node biopsy, EUR J SUR O, 26(5), 2000, pp. 515-516
Stem cells research: Impact on molecular biology of cancer and prospects for therapy of neoplastic diseases
Authors: Anichini, A Cascinelli, N
Citation: A. Anichini et N. Cascinelli, Stem cells research: Impact on molecular biology of cancer and prospects for therapy of neoplastic diseases, TUMORI, 86(5), 2000, pp. 375-380
Sentinel node biopsy in patients with cutaneous melanoma of the head and neck
Authors: Maffioli, L Belli, F Gallino, G Ditto, A Castellani, MR Testoni, M Sturm, E Bombardieri, E Cascinelli, N
Citation: L. Maffioli et al., Sentinel node biopsy in patients with cutaneous melanoma of the head and neck, TUMORI, 86(4), 2000, pp. 341-342
Association between cutaneous melanoma and neurofibromatosis type 1: Analysis of three clinical cases and review of the literature
Authors: Gallino, G Belli, F Tragni, G Ferro, F Massone, PPB Ditto, A Leo, E Cascinelli, N
Citation: G. Gallino et al., Association between cutaneous melanoma and neurofibromatosis type 1: Analysis of three clinical cases and review of the literature, TUMORI, 86(1), 2000, pp. 70-74
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma
Authors: Crippa, F Leutner, M Belli, F Gallino, F Greco, M Pilotti, S Cascinelli, N Bombardieri, E
Citation: F. Crippa et al., Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma, J NUCL MED, 41(9), 2000, pp. 1491-1494
Breast carcinoma in young patients
Authors: Menard, S Casalini, P Cascinelli, N Balsari, A
Citation: S. Menard et al., Breast carcinoma in young patients, LANCET, 356(9235), 2000, pp. 1113-1113
A new American Joint Committee on Cancer staging system for cutaneous melanoma
Authors: Balch, CM Buzaid, AC Atkins, MB Cascinelli, N Coit, DG Fleming, ID Houghton, A Kirkwood, JM Mihm, MF Morton, DL Reintgen, D Ross, MI Sober, A Soong, SJ Thompson, JA Thompson, JF Gershenwald, JE McMasters, KM
Citation: Cm. Balch et al., A new American Joint Committee on Cancer staging system for cutaneous melanoma, CANCER, 88(6), 2000, pp. 1484-1491
Breast cancer patients treated without axillary surgery - Clinical implications and biologic analysis
Authors: Greco, M Agresti, R Cascinelli, N Casalini, P Giovanazzi, R Maucione, A Tomasic, G Ferraris, C Ammatuna, M Pilotti, S Menard, S
Citation: M. Greco et al., Breast cancer patients treated without axillary surgery - Clinical implications and biologic analysis, ANN SURG, 232(1), 2000, pp. 1-7
Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients
Authors: Cascinelli, N Belli, F Gallino, G Lenisa, L
Citation: N. Cascinelli et al., Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients, PROG ANTI C, 4, 2000, pp. 235-242
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Sanantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells, HUM GENE TH, 10(18), 1999, pp. 2907-2916
Importance of the level of axillary involvement in relation to traditionalvariables in the prognosis of breast cancer
Authors: Zurrida, S Morabito, A Galimberti, V Luini, A Greco, M Bartoli, C Raselli, R Rossi, N Vessecchia, G Cascinelli, N Veronesi, U
Citation: S. Zurrida et al., Importance of the level of axillary involvement in relation to traditionalvariables in the prognosis of breast cancer, INT J ONCOL, 15(3), 1999, pp. 475-480
Small melanomas: a clinical study on 270 consecutive cases of cutaneous melanoma
Authors: Bono, A Bartoli, C Moglia, D Maurichi, A Camerini, T Grassi, G Tragni, G Cascinelli, N
Citation: A. Bono et al., Small melanomas: a clinical study on 270 consecutive cases of cutaneous melanoma, MELANOMA RE, 9(6), 1999, pp. 583-586
Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients
Authors: Lenisa, L Santinami, M Belli, F Clemente, C Mascheroni, L Patuzzo, R Gallino, G Bergonzi, M Rao, S Polverelli, M Morelli, R Landi, G Cascinelli, N
Citation: L. Lenisa et al., Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients, J EXP CL C, 18(1), 1999, pp. 69-74
Cancer prevalence in Italy: The ITAPREVAL study - Foreward
Authors: Cascinelli, N
Citation: N. Cascinelli, Cancer prevalence in Italy: The ITAPREVAL study - Foreward, TUMORI, 85(5), 1999, pp. 307-308
Risultati: 1-25 | 26-28